Think Research
Knowledge-based tools and leading clinical content for clinicians at the point of care.
Launch date
Employees
Market cap
CAD24.8m
Enterprise valuation
CAD72m (Public information from Apr 2024)
Share price
CAD0.315 THNK.V
Toronto Ontario (HQ)
Financials
Estimates*
CAD | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Revenues | 19.4m | 47.8m | 78.6m | 84.1m | 91.4m |
% growth | - | 146 % | 64 % | 7 % | 9 % |
EBITDA | (6.9m) | (13.8m) | (5.4m) | 1.6m | 6.7m |
% EBITDA margin | (35 %) | (29 %) | (7 %) | 2 % | 7 % |
Profit | (10.0m) | (29.0m) | (25.7m) | (14.7m) | (14.9m) |
% profit margin | (52 %) | (61 %) | (33 %) | (18 %) | (16 %) |
EV / revenue | 8.3x | 2.5x | 0.9x | 0.8x | 0.9x |
EV / EBITDA | -23.3x | -8.7x | -12.4x | 42.4x | 12.1x |
R&D budget | 4.5m | 6.6m | 6.8m | - | - |
R&D % of revenue | 23 % | 14 % | 9 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Early VC | |
CAD5.0m | Series A | ||
CAD25.0m | Series B | ||
$25.0m | Late VC | ||
N/A | N/A | IPO | |
CAD25.0m | Series D | ||
N/A | N/A | IPO | |
* | CAD25.0m | Post IPO Debt | |
* | N/A | Post IPO Debt | |
* | $1.5m | Post IPO Debt | |
* | N/A Valuation: $25.4m | Acquisition | |
Total Funding | CAD89.1m |
Recent News about Think Research
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Think Research
EditACQUISITION by Think Research Nov 2021
ACQUISITION by HEALWELL Jun 2024
ACQUISITION by Think Research Jan 2021
ACQUISITION by Think Research Feb 2021